MolecuLight i:X TM
Wound Intelligence Device
The MolecuLight i:X allows clinicians to quickly, safely, and easily visualize bacteria and measure wounds at the point of care, so they have maximum insights for accurate treatment selection and accelerated healing.1,2,3
What Does MolecuLight i:X Do?
Making a Difference in Wound Care
How Does it Work?
Leveraging the principle of fluorescence, the MolecuLight i:X Wound Intelligence Device emits safe violet light which causes bacteria ≥ 104 CFU/g to fluoresce.4 The bacterial fluorescence signals detected by the device provide healthcare professionals with a visual indication of bacterial presence, load, and location within and around wounds in real-time to guide clinicians in their selection, application, and response monitoring of wound therapies.2,8,9
1. Wu YC, Smith M et al. Handheld fluorescence imaging device detects subclinical wound infection in an asymptomatic patient with chronic diabetic foot ulcer: a case report. Int Wound J. 2016 Aug;13(4):449-53.
2. DaCosta RS et al. Point-of-care autofluorescence imaging for real-time sampling and treatment guidance of bioburden in chronic wounds: first-in-human results. PLoS One. 2015 Mar 19;10(3).
3. Ottolino-Perry K et al. Improved detection of clinically relevant wound bacteria using autofluorescence image-guided sampling in diabetic foot ulcers. Int Wound J. 2017; doi: 10.1111/iwj.12717.
4. Rennie MY et al. (2017). Point-of-care fluorescence imaging predicts the presence of pathogenic bacteria in wounds: a clinical study. Journal of Wound Care; 2017 Aug 2; Vol 26 (8), 452-460. doi: 10.12968/jowc.2017.26.8.452.
5. Raizman R. Point-of-care fluorescence imaging device guides care and patient education in obese patients with surgical site infections. Presented at: CAWC 2016. Proceedings of the 22nd Annual Canadian Association of Wound Care Conference; 2016 Nov 3-6, Niagara Falls, ON.
6. Jeffery, S. Utility of point-of-care autofluorescence imaging device in successful closure of major limb amputations – a case study. Presented at: MHSRS 2016. Proceedings of the Military Health System Research Symposium; 2016 Aug 15-18; Kissimmee, FL.
7. MolecuLight Inc. Case Study 0051 Track Wound Size and Bacterial Presence with the MolecuLight i:X. 2016.
8. Wu YC et al. Autofluorescence imaging device for real-time detection and tracking of pathogenic bacteria in a mouse skin wound model: preclinical feasibility studies. J Biomed Opt. 2014 Aug;19(8).
9. Raizman R et al. Handheld real-time fluorescence imaging of bacteria guides treatment selection and timing of dressing changes in inpatients undergoing negative pressure wound therapy. Proceedings of the Innovations in Wound Healing Conference; 2016 Dec 8-11, Key Largo, FL.
10. Landis SL et al. Use of fluorescence imaging in visualizing bacteria in chronic ulcers and traumatic soft tissue damage. Proceedings of the Annual Meeting of the Society of Federal Health Professionals (AMSUS); 2016 Nov 29-Dec 2; National Harbor, MD.
11. Landis SJ. Mapping venous ulcers using bacterial autofluorescence (BAF) to identify subgroups at risk of infection post debridement. Proceedings of the Annual Canadian Association of Wound Care Conference; 2016 Nov 3-6, Niagara Falls, ON.
12. Hill R et al. Effect of bacterial fluorescence imaging on patient care and wound
management in a hospital setting: a pilot study. Proceedings of the Annual Symposium on Advanced Wound Care (SAWC); 2017 Apr 5-9; San Diego, CA.
13. Hill R et al. Real-time bacterial fluorescence imaging guides antimicrobial stewardship in patients with diverse wounds. Proceedings of the Annual Symposium on Advanced Wound Care (SAWC); 2017 Apr 5-9; San Diego, CA.
14. MolecuLight Inc. PN 1189 MolecuLight i:X User Manual. 2016.
15. Raizman R. Fluorescence imaging positively predicts bacterial presence and guides wound cleaning and patient education in a series of pilonidal sinus patients. Proceedings of the Annual Wounds UK Conference; 2016 Nov 14-16; Harrogate, UK.